바이젠셀 Stock: price and insider trades · South Korea
No insider purchase over the last 90 days. The latest, by 신영배, was filed 05 Jan 2026.
Who traded when
BuySaleTransparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 30,520 sharesKRXDART:20260331003226
- 30,520 sharesShareKRXDART:20260331003190
- 1,163,357 sharesShareKRXDART:20260128000382
- 1,163,357 sharesKRXDART:20260126000314
- 10,000 sharesShareKRXDART:20260105000207Canonical exit: 5 Apr 2026 (T+90)
- 40,520 sharesKRXDART:20251231000519Canonical exit: 30 Mar 2026 (T+90)
- ●Executives0DART
- ●Executives0DART
- 356,191 sharesKRXDART:20251216000038
- 215,100 sharesKRXDART:20251216000039
- 356,191 sharesKRXDART:20251209000114
- 32,480 sharesShareKRXDART:20251209000125
- 22,640 sharesShareKRXDART:20251209000121Canonical exit: 9 Mar 2026 (T+90)
- 1,181,573 sharesKRXDART:20251202000365
- ●Executives0DART
- 2,190,000 sharesShareKRXDART:20250204000182Canonical exit: 5 May 2025 (T+90)
- 2,777,764 sharesKRXDART:20241224000104Canonical exit: 18 Mar 2025 (T+90)
- 4,378,320 sharesKRXDART:20241220000664Canonical exit: 18 Mar 2025 (T+90)
- 5,245,580 sharesKRXDART:20241220000557
- 266,454 sharesKRXDART:20240116000110Canonical exit: 10 Apr 2024 (T+90)
- ShareKRXDART:20231030000202
- ShareKRXDART:20231030000196
- ShareKRXDART:20230615000340
- ShareKRXDART:20220831001136
- ShareKRXDART:20220615000310
25 of 47 declarations
About 바이젠셀
바이젠셀, a South Korean healthcare company valued at KRW 113.2 billion, has 47 filings from 8 filers, published from August 31, 2021 to March 31, 2026. Sales outweigh purchases: 17 sales against 7 purchases, so 29% of open-market trades are purchases, plus 23 filings of another nature. Insiders hold 26.1% of the shares.
보령, listed as a holder of 10% or more, is the top filer with 28 filings, 9 of them sales and none a purchase. 가은글로벌, a major holder (대량보유자), has 7 filings (3 purchases, 2 sales), and 김태규, also a major holder, 5 (1 purchase, 4 sales). 김경묵, a senior vice president (부사장), filed 2 sales, and 김병수, a director, 2 filings including 1 purchase.
Read moreShow less
From December 9, 2025 to January 5, 2026, three insiders bought within one window. The yearly pace is 11 filings in 2021, 13 in 2022, 3 in 2023, 4 in 2024, 11 in 2025 and 5 in 2026. The last twelve months hold 14 filings, including 3 purchases and 9 sales. The median publication delay is 5 days.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
